Related references
Note: Only part of the references are listed.Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
Ciara McCabe et al.
BIOLOGICAL PSYCHIATRY (2010)
Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
M-H Son et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain
Nancy A. Rigotti et al.
ADDICTION (2009)
Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action
Catherine J. Harmer et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure
Aaron N. A. Verty et al.
OBESITY (2009)
The psychiatric side-effects of rimonabant
Fabricio A. Moreira et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2009)
Neural representation of reward in recovered depressed patients
Ciara McCabe et al.
PSYCHOPHARMACOLOGY (2009)
The future of endocannabinoid-oriented clinical research after CB1 antagonists
Bernard Le Foll et al.
PSYCHOPHARMACOLOGY (2009)
Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats
Clare M. Mathes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats
Paola Maccioni et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Additive subthreshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests
Eiki Takahashi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease -: The STRADIVARIUS randomized controlled trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity:: Effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats
F. J. Pavon et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice
Michel A. Steiner et al.
PSYCHONEUROENDOCRINOLOGY (2008)
Cognitive influences on the affective representation of touch and the sight of touch in the human brain
Ciara McCabe et al.
SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE (2008)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Enhanced affective brain representations of chocolate in cravers vs. non-cravers
Edmund T. Rolls et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Umami: a delicious flavor formed by convergence of taste and olfactory pathways in the human brain
Ciara McCabe et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats
GL Gessa et al.
PSYCHOPHARMACOLOGY (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The neural correlates of anhedonia in major depressive disorder
PA Keedwell et al.
BIOLOGICAL PSYCHIATRY (2005)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Rimonabant: The first therapeutically relevant cannabinoid antagonist
MAM Carai et al.
LIFE SCIENCES (2005)
Endocannabinoid control of food intake and energy balance
V Di Marzo et al.
NATURE NEUROSCIENCE (2005)
Inverse agonism and neutral antagonism at cannabinoid CBI receptors
RG Pertwee
LIFE SCIENCES (2005)
Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling
S Patel et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents
G Griebel et al.
BIOLOGICAL PSYCHIATRY (2005)
Differential neural responses to overt and covert presentations of facial expressions of fear and disgust
ML Phillips et al.
NEUROIMAGE (2004)
The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology
ML Kringelbach et al.
PROGRESS IN NEUROBIOLOGY (2004)
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats
G Colombo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Neural correlates of internally-generated disgust via autobiographical recall: a functional magnetic resonance imaging investigation
DA Fitzgerald et al.
NEUROSCIENCE LETTERS (2004)
Direct activation of the ventral striatum in anticipation of aversive stimuli
J Jensen et al.
NEURON (2003)
Human cortical responses to water in the mouth, and the effects of thirst
IET de Araujo et al.
JOURNAL OF NEUROPHYSIOLOGY (2003)
Different representations of pleasant and unpleasant odours in the human brain
ET Rolls et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
JA Maldjian et al.
NEUROIMAGE (2003)
Fast, fully automated global and local magnetic field optimization for fMRl of the human brain
JL Wilson et al.
NEUROIMAGE (2002)
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
C Cohen et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Classical and Bayesian inference in neuroimaging: Applications
KJ Friston et al.
NEUROIMAGE (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
A cannabinoid mechanism in relapse to cocaine seeking
TJ De Vries et al.
NATURE MEDICINE (2001)
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
L De Petrocellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
